Crinetics gets first FDA approval as Palsonify is cleared for rare hormonal disorder

Crinetics won FDA approval for Palsonify to treat a rare condition that occurs when the pituitary gland produces too much growth hormone. The company said Thursday that Palsonify, also known as ...